Vaccines against coronavirus and methods of use

US11660335B2 · kind B2 · utility

Assignees

• Inovio Pharmaceuticals, Inc. · US
• The Wistar Institute of Anatomy and Biology · US

Inventors

• Jian Yan · Wallingford, US
• Kate Broderick · San Diego, US
• David B. Weiner · Yeadon, US
• Kar Muthumani · Cherry Hill, US
• Ami Patel · Philadelphia, US

Key dates

• Filing date: Feb 25, 2021
• Grant date: May 30, 2023
• Expiry date: Feb 25, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2770/20044
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen, SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune responses and protecting against or treating a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection in a subject.